Al Mansouri, Shamma, et al. “The cannabinoid receptor 2 agonist, β-caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice.” Pharmacology Biochemistry and Behavior 124 (2014): 260-268.
Bahi, Amine, et al. “β-Caryophyllene, a CB 2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice.” Physiology & behavior 135 (2014): 119-124.
Campos, Alline Cristina, and Francisco Silveira Guimarães. “Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats.” Psychopharmacology 199.2 (2008): 223-230.
Colasanti, Brenda K., Charles R. Craig, and R. David Allara. “Intraocular pressure, ocular toxicity and neurotoxicity after administration of cannabinol or cannabigerol.” Experimental eye research 39.3 (1984): 251-259.
Deiana, Serena, et al. “Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour.” Psychopharmacology 219.3 (2012): 859-873.
Hayakawa, Kazuhide, et al. “Repeated treatment with cannabidiol but not Δ 9-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance.” Neuropharmacology 52.4 (2007): 1079-1087.
Hillig, Karl W., and Paul G. Mahlberg. “A chemotaxonomic analysis of cannabinoid variation in Cannabis (Cannabaceae).” American Journal of Botany 91.6 (2004): 966-975
Huestis, M. A. “Pharmacokinetics and Metabolism of the Plant Cannabinoids, Δ 9-Tetrahydrocannibinol, Cannabidiol and Cannabinol.” Cannabinoids. Springer Berlin Heidelberg, 2005. 657-690.
Lee, Martin. “Sourcing CBD: Marijuana, Industrial Hemp and the Vagaries of Federal Law.” https://www.projectcbd.org/article/sourcing-cbd-marijuana-industrial-hemp-vagaries-federal-law
McPartland, John M., and Ethan B. Russo. “Cannabis and cannabis extracts: greater than the sum of their parts?” Journal of Cannabis Therapeutics 1.3-4 (2001): 103-132.
Moldzio, Rudolf, et al. “Effects of cannabinoids Δ (9)-tetrahydrocannabinol, Δ (9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures.” Phytomedicine 19.8 (2012): 819-824.
Novak, Johannes, et al. “Essential oils of different cultivars of Cannabis sativa L. and their antimicrobial activity.” Flavour and fragrance journal 16.4 (2001): 259-262.
Pertwee, R. G., et al. “The psychoactive plant cannabinoid, Δ9‐tetrahydrocannabinol, is antagonized by Δ8‐and Δ9‐tetrahydrocannabivarin in mice in vivo.” British journal of pharmacology 150.5 (2007): 586-594.
Petitet, François, et al. “Complex pharmacology of natural cannabivoids: Evidence for partial agonist activity of Δ 9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors.” Life sciences 63.1 (1998): PL1-PL6.
Rock, Erin M., et al. “Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews.” Psychopharmacology 215.3 (2011): 505-512.
Russo, Ethan B. “Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects.” British Journal of Pharmacology 163.7 (2011): 1344-1364.
Russo, Ethan B. "Beyond Cannabis: Plants and the Endocannabinoid System." Trends Pharmacol Sci (2016) 37 (7):594-605.
van Dam, Rob M., Nasheen Naidoo, and Rikard Landberg. “Dietary flavonoids and the development of type 2 diabetes and cardiovascular diseases: review of recent findings.” Current opinion in lipidology 24.1 (2013): 25-33.
Verhoeckx, Kitty CM, et al. “Unheated Cannabis sativa extracts and its major compound THC-acid have potential immuno-modulating properties not mediated by CB 1 and CB 2 receptor coupled pathways.” International immunopharmacology 6.4 (2006): 656-665.
Woo HD, Kim J (2013). “Dietary flavonoid intake and smoking-related cancer risk: a meta-analysis”. PLoS ONE 8 (9): e75604.
Zamora-Ros R., et al. “Dietary flavonoid and lignan intake and gastric adenocarcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr (2012) 96:1398–408.